Клинико-морфологический и популяционный анализ рака желудка с оценкой критериев выживаемости
Диссертация
Научная новизна исследования. Впервые проведено многоуровневое (популяционное, госпитальное) и многоплановое (клинико-морфологическое, ИГХ, прогностическое) исследование РЖ. Научно обоснованы современные медико-демографические клинико-морфологические и прогностические особенности РЖ: возрастно-половая, с установлением контингентов риска, и морфологическая структурапоказатели… Читать ещё >
Список литературы
- Анализ современного патоморфоза рака желудка на популяционном уровне / И. А. Данилова и др. // Мед. акад. журн. 2008. — Т. 8, № 3. — С. 35 -45.
- Аничков, Н.М. Биология опухолевого роста (молекулярно-медицинские аспекты) / Н. М. Аничков, И. М. Кветной, С. С. Коновалов. — СПб.: «Издательство „ПРАЙМ-ЕВРОЗНАК“», 2004. 224 с.
- Аничков, Н.М. Новое в учении об инвазии опухолевых клеток / Н. М. Аничков // Арх. патол. 2004. — № 1. С. 59 — 62.
- Аруин, Л.И. Рак желудка / Л. И. Аруин // Росс. журн. гастроэнтерологии, гепатологии, колопроктологии. 1999. — Т. 9, № 1. — С. 72−78.
- Безуглова, Т.В. Роль иммуногистохимического исследования компонентов внеклеточного матрикса в оценке злокачественного потенциала надпочечниковых феохромоцитом / Т. В. Безуглова, Г. А. Полякова, И. А. Казанцева // Арх. патол. 2008. — № 6. — С. 19 — 21.
- Большакова, Г. Б. Молекулярные механизмы репарации в пренатальном периоде / Г. Б. Большакова // Арх. патол. — 2008. — № 6. С. 53 -56.
- Василенко, И.В. Изменения слизистой оболочки желудка при диффузном и кишечном раке / И. В. Василенко, Н. Н. Сургай, Ю. Д. Сидорова // Арх. патол. 2001. — № 4. С. 26 — 29.
- Василенко, И.В. Паренхиматозно-стромальные взаимоотношения в опухолях и их особенности при раке желудка кишечного и диффузного типа / И. В. Василенко, Р. Б. Кондратюк // Онкология. 2006. — Т. 8, № 1. — С. 7 — 12.
- Гаршин, В.Г. Воспалительные разрастания эпителия, их биологическое значение и отношение к проблеме рака / В. Г. Гаршин. — М. -Л.: Медгиз, 1939.-129 с.
- Головин, Д.И. Техника вскрытия трупов методом полной эвисцерации / Д. И. Головин. — Ленинград: ЛСГМИ, 1981. — 69 с.
- Головин, Д.И. Ошибки и трудности гистологической диагностики опухолей / Д. И. Головин. Л.: «Медицина», 1982. — 304 с.
- Данилова, И.А. Опухоли желудка / М. А. Пальцев, Н. М. Аничков // Атлас патологии опухолей человека. М.: ОАО «Издательство «Медицина», 2005.-Гл. 9.-С. 199−212.
- Данилова И.А. Клинико-морфологическая характеристика рака желудка на ранних этапах прогрессии / И. А. Данилова // Вест. СПбГМА им. И. И. Мечникова. 2006.-№ 3 (7). — С. 111−115.
- Данилова, И.А. Комплексное изучение основных морфологических форм рака желудка в связи с показателями их прогностической оценки / И. А. Данилова, Н. М. Аничков //Арх. патол. 2009. — № 5. — С. 27 — 31.
- Журавлева, Т.Б. Система «эпителий соединительная ткань» и межструктурная кооперация при воспалении / Т. Б. Журавлева // Общие и частные вопросы воспаления и иммунитета: сб. науч.тр. — СПб, 1988. — С. 16 -21.
- Журавлева, Т.Б. Межструктурная кооперация при различных видах патологической пролиферации эпителия / Т. Б. Журавлева, М. Г. Рыбакова // Актуальные вопросы онкоморфологии: сб. науч.тр. — С.-Пб. — Киров, 1996. — С. 37−42.
- Заболеваемость населения России злокачественными новообразованиями в 2000 году / В. В. Старинский и др. // Росс, онкол. журн. 2002. — № з. с. 39 — 44.
- Калиновский, В.П. Рак желудка: факторы риска, меры профилактики / В. П. Калиновский, А. Р. Шумаков, Е. И. Ткаченко // Мед. академ. журн. -2008. Т. 8, № 4. — С. 86 — 96.
- Коган, Е.А. Опухолевый рост (Биомолекулярные маркеры опухолей) / Е. А. Коган // Лекции по общей патологической анатомии (учебное пособие) / под ред. М. А. Пальцева. М.: ООО «Издательский дом «Русский врач», 2003.-С. 231 -253.
- Количественная иммуногистохимия: оптимизация анализа экспрессии сигнальных молекул в миометрии / М. Ю. Смирнова и др. // Арх. патол. 2010. — № 1.-С. 51−55.
- Краевский, H.A. Руководство по патологоанатомической диагностике опухолей человека / H.A. Краевский. М.: Медицина, 1986. -529 с.
- Матриксные металлопротеиназы, их ингибиторы и ангиогенез при различных морфологических вариантах предрака легкого у жителей радиоактивно-загрязненных территорий Семипалатинской области
- Казахстана / Г. Е. Сагиндикова и др. // Арх. патол. 2008. — № 2. — С. 21 -25.
- Международная статистическая классификация болезней и проблем, связанных со здоровьем (МКБ-10). Десятый пересмотр: сборник. Т. 1 (часть 1). — М.: Изд-во «Медицина», 1995 — с. 698.
- Мерабишвили, В.М. Выживаемость онкологических больных / В. М. Мерабишвили. СПб: «Издательско-полиграфическая компания «КОСТА» 2006.-430 с.
- Мерабишвили, В.М. Злокачественные новообразования в мире, России, Санкт-Петербурге / В. М. Мерабишвили СПБ: ООО «Издательско-полиграфическая компания «КОСТА», 2007. — 424 с.
- Мерабишвили, В.М. Онкологическая служба в Санкт-Петербурге и районах города в 2008 году (заболеваемость, смертность, выживаемость). Ежегодник ПРР / В. М. Мерабишвили, Ю. А. Щербук. СПб: ООО «Издательско-полиграфическая компания «КОСТА», 2009. — 240 с.
- Мерабишвили, В.М. Онкологическая служба в Санкт-Петербурге и районах города в 2009 году. Ежегодник Популяционного ракового регистра (№ 16) / В. М. Мерабишвили, Ю. А. Щербук. СПб: ООО «А-ВИР», ООО «ИПК «КОСТА», 2010. — 224 с.
- Морфологическая оценка эффективности местных иммунных реакций при раке желудка / Е. А. Дикштейн и др. // Арх. патол. 1988. — Т. 50, № 12.-С. 24−30.
- Москвина, JI.B. Современные представления о молекулярных механизмах прогрессии рака желудка / JI.B. Москвина, П. Г. Мальков // Арх. патол.-2010.-№ 4.-С. 58−61.
- Опухоли пищеварительной системы. Желудок / К. Виттекинд и др. // TNM Атлас. Иллюстр. руководство по TNM классификации злокачественных опухолей. 5-е издание / под. ред. Ш. Х. Ганцева. — М.: ООО «Медицинское информационное агентство», 2007. С. 84−95.
- Пайкова, JI.B. Рак желудка на почве хронической язвы (вопросы гистологии и гистогенеза) / JI.B. Пайкова // Арх. патол. 1982. — Т. 44, № 9. — С. 13−19.
- Пальцев, М.А. Патологическая анатомия и молекулярная диагностика / М. А. Пальцев, Е. С. Северин, A.A. Иванов // Арх. патол. — 2006.- № 4. С. 3 — 7.
- Пальцев, М.А. Патология человека: Учебник. В 2 томах. Том.2. Частный курс, ч. 1 / М. А. Пальцев, Н. М. Аничков, П. Ф. Литвицкий. М.: ОАО ««Издательство «Медицина»», 2009. — 576 с.
- Патология: Руководство / под ред. М. А. Пальцева, B.C. Паукова, Э. Г. Улумбекова. М.: ГЭОТАР-МЕД, 2002. — 960 с.
- Петров, С.В. Руководство по иммуногистохимической диагностике опухолей человека. Изд. 3-е, дополн. и перераб. / С. В. Петров, Н. Т. Райхлин.- Казань, 2004. 456 с.
- Применение раствора полигуанидина для фиксации биологических и анатомических объектов / Н. М. Аничков и др. // Морфология. 2010. — Т. 137, № 1. С. 58−61.
- Серов, В.В. Клиническая морфология и прогноз рака желудка / В. В. Серов. -М.: Медицина, 1970. 159 с.
- Системы генетических и эпигенетических маркеров в диагностике онкологических заболеваний / под ред. М. А. Пальцева, Д. В. Залетаева. М.: ОАО «Издательство «Медицина», 2009. — 384 с.
- Склянская, O.A. Болезни органов пищеварительной системы / O.A. Склянская // Курс лекций по патологической анатомии. Частный курс / под ред. М. А. Пальцева. М.: М.: ООО «Издательский дом «Русский врач», 2003.- Часть II (книга 1). С. 4 43.
- Характеристика воспалительного инфильтрата слизистой оболочки желудка у больных с дисплазией П-Ш степени и раком желудка / В. А. Евтушенко и др. // Клин. мед. 2008. — Т. 86, № 11. — С. 48 — 53.
- Чиссов, В.И. Злокачественные новообразования в России в 2008 году (заболеваемость, смертность) / В. И. Чиссов, В. В. Старинский, Г. В. Петрова. -М.: ФГУ «МНИОИ им. П. А. Герцена Росмедтехнологий», 2010. 256 с.
- Экспрессия KI-67 и Р53 при дисплазии и раке желудка / А. Ф. Лазарев и др. // Арх. патол. 2006. — № 3. — С. 6 — 10.
- Ackerman, L.V. Cancer. Diagnosis, treatment, and prognosis / L.V. Ackerman, del Regato. Saint Louis: J.A. The C.V. Mosby Company, 1962.
- A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa / M. Bromley et al. //- Eur. J. Histochem. 1996. — Vol. 40. — P. 89 — 100.
- Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2 / K. Kayano et al. // J Pathol. 2004. — Vol. 202. — P. 403 — 411.
- Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation / A. Bouloumie et al. // Diabetes 2001. — Vol. 50. — P. 2080−2086.
- A functional overlap of plasminogen and MMPs regulates vascularization during placental development / H. Solberg et al. // Development. 2003. — Vol. 130.-P. 4439−4450.
- Ajisaka, H. Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer / H. Ajisaka, Y. Yonemura, K. Miwa // Hepatogastroenterology. 2004. — Vol. 51. P. 900 — 905.
- Akslen, L.A. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma / L.A. Akslen., V.A. LiVolsi // Cancer. 2000. — Vol. 88, 8. — P. 1902 — 1908.
- Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer / G.C. Durkan et al. // Clin. Cancer Res. 2003. — Vol. 9. — P. 2576 — 2582.
- Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis / P. Wulfing et al. // J Cancer Res Clin Oncol. 2003. — Vol. 129, N. 7. — P. 375 — 382.
- Androgen receptor expression in breast cancer: Relationship with clinico-pathological characteristics of the tumors, prognosis, and expression of metallo-proteases and their inhibitors / L. O. Gonzalez et al. // BMC Cancer 2008. -Vol. 8. — P. 149.
- A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 / J. H. Qi et al. // Nat. Med. 2003. — Vol. 9. — P. 407 — 415.
- A novel role of metalloproteinase in cancer-mediated immunosuppression / B.C. Sheu et al. // Cancer Res. 2001. — Vol. 61. — P. 237 — 242.
- A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study / K. Shikata et al. // Int. J. Cancer.-2006.-Vol. 119.-P. 196−201.
- A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes / N.D. Freedman et al. // Am. J. Epidemiol. 2007. -Vol. 165.-P. 1424−1433.
- Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling / L. Scorrano et al. // J Biol Chem. 2001. — Vol. 276, N. 15. — P. 12 035 — 12 040.
- Asia-Pacific consensus guidelines on gastric cancer prevention / K.M. Fock et al. // J Gastroenterol Hepatol. 2008. — Vol. 23, N. 3. — P. 351 — 365.
- Baker, A.H. Metalloproteinase inhibitors: biological actions and therapeutic opportunities / A.H. Baker, D.R. Edwards, G. Murphy // Journal of Cell Science. 2002. — Vol. 115. — P. 3719 — 3727.
- Biochemistry and molecular biology of gelatinase B or matrix metallo-proteinase-9 (MMP-9) / Van Den Steen et al. // Crit. Rev. Biochem. Mol. Biol. -2002. Vol. 37. — P. 375 — 536.
- Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment / S.Y. Rha et al. // Int. J. Mol. Med. 2002. — Vol. 10, N. 3. — P. 251 — 256.
- Body size and composition and the risk of gastric and oesophageal adenocar-cinoma / R.J. Maclnnis et al. // Int. J. Cancer. 2006. — Vol. 119. — P. 2628−2631.
- Borrmann, R. Geschwulste des Magens und Duodenums / R. Borrmann // Der speziellen pathologischen Anatomie und Histologie: Handbuch / v. Henke-Lubarsch. Berlin.: Julius Springer, 1926. — Bd. IY, N. 1.
- Brenner, H. Epidemiology of stomach cancer / H. Brenner, D. Rothenbacher, V. Arndt // Methods Mol Biol. 2009. — Vol. 472. — P. 467 — 477.
- Brew, K. Tissue inhibitors of metalloproteinases: evolution, structure and function / K Brew, D. Dinakarpandian, H. Nagase // Biochim Biophys Acta. -2000. Vol. 1477. — P. 267 — 283.
- Brinckerhoff, C. E. Matrix metalloproteinases: a tail of a frog that became a prince / C.E. Brinckerhoff, L.M. Matrisian // Nat. Rev. Mol. Cell Biol. 2002. -Vol. 3.-P. 207−214.
- Carneiro, F. New Elements for an Updated Classification of the Carcinoma of the Stomach / F. Carneiro, M. Sexas, M. Sobrinho-Simoes // Path. Res. Pract. 1995. — Vol. 191. — P. 571−584.
- Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25) / W.R. English et al. // FEBS Lett 2001. — Vol. 491. — P. 137 — 142.
- Cervello, M. Cyclooxygenases in hepatocellular carcinoma / M. Cervello, G. Montalto // World J Gastroenterol. 2006. — Vol. 12, N. 32. — P. 5113 — 5121.
- Changes in the histologic types of gastric carcinoma in Japan / Y. Kato et al. // Cancer. -1981. -Vol. 48, N. 9. P. 2084 — 2087.
- Characteristics of lymph node metastasis and prognostic analysis in 157 early gastric cancer patients / Z.M. Wu et al. // Zhonghua Wei Chang Wai Ke Za Zhi. 2009. — Vol. 12, N. 4. — P. 350 — 353.
- Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature / P. Aurello et al. // Am. Surg. 2007. — Vol. 73, N. 4. — P. 359 — 366.
- Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers / H. Toyoki et al. // Ann Oncol. -2005.-Vol. 16, N. l.-P. 51−55.
- Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma / Y. Imanishi et al. // Hum. Pathol. 2000. — Vol. 31.-P. 895 — 904.
- Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer / K.N. Shim et al. // J. Gastro-enterol. 2007. — Vol. 42, N. 2. — P. 120 — 128.
- Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma / M. Hermanova et al. // Pancreas. 2009. — Vol. 38, N. 5. — P. 565 — 571.
- Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis / A. Kabashima et al. // Clin Cancer Res. 2000. — Vol. 6. — P. 3581−3584
- Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China / L. Shen et al. // Can J Gastroenterol. 2009. — Vol. 23, N. 5. — P. 353 — 356.
- Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma / C.N. Chen et al. // Ann. Surg. 2001. -Vol. 233, N. 2.-P. 183- 188.
- Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas / B.S. Nielsen et al. // Cancer Res. 2001. — Vol. 61. — P. 7091 — 7100.
- Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus / M. Balbin et al. // J Biol Chem. 1998. — Vol. 273, N. 37. — P. 23 959 — 23 968.
- Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms / G. Ghilardi et al. // Clin. Chem. 2003. — Vol. 49. — P. 1940 — 1942.
- Comparison in pathological behaviours and prognosis of gastric cancers from general hospitals between China and Japan / M. Yu et al. // Indian J Med Res. -2010. Vol. 132. — P. 295 — 302.
- Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus / C.J. Buslcens et al. // Gut. 2003. — Vol. 52, N. 12.-P. 1678- 1683.
- Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice / S. Huang et al. // J. Natl. Cancer Inst. -2002. Vol. 94. — P. 1134 — 1142.
- Cook, H.C. Manual of Histological Demonstration / H.C. Cook. -London: Butterworths, 1974.
- Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1- deficient mice / L.A. Rudolph-Owen et al. // Endocrinology. 1997. — Vol. 138. — P. 4902 — 4911.
- Corley, D.A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas / D.A. Corley, A. Kubo // J. Natl. Cancer Inst. -2004.-Vol. 15, N. 96 (18).-P. 1383- 1387.
- Correa, P. The biological model of gastric carcinogenesis / P. Correa // IARC Sci Publ. 2004. — Vol. 157. — P. 301 — 310.
- Correa, P. Etiology of gastric cancer: what is new? / P. Correa, B.G. Schneider // Cancer Epidemiol. Biomarkers Prev. 2005. — Vol. 14, N. 8. — P. 1865- 1868.
- Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer / G. Davies et al. // Clin Cancer Res. 2003. — Vol. 9, N. 7. -P. 2651 -2656.
- Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival / G. Spizzo et al. // Br J Cancer. 2003. -Vol. 88, N. 4.-P. 574−578.
- Correlation of histological classifications of gastric carcinomas with location and prognosis / C.N. Demirkan et al. // Gastroenterol. Clin. Biol. 2002. — Vol. 26, N. 6 — 7. — P. 610 — 615.
- Coussens, L. M. Inflammation and cancer / L.M. Coussens, Z. Werb // Nature. 2002. -Vol. 420. — P. 860 — 867.
- COX-2 expression in canine mammary carcinomas: correlation with angio-genesis and overall survival / G.E. Lavalle et al. // Vet. Pathol. 2009. -Vol. 46.-P. 1275−1280.
- COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray / X.Y. Mao et al. // World J Gastroenterol. -2007. Vol. 13, N. 25. — P. 3466 — 3471.
- COX-2 expression in malignant melanoma: a novel prognostic marker? / M. R. Becker et al. // Melanoma Res. 2009. — Vol. 19, N. 1. — P. 8 — 16.
- Cox-2 expression on tissue microarray of breast cancer / K. Park et al. // Eur J Surg Oncol. 2006. — Vol. 32, N. 10. — P. 1093 — 1096.
- COX-2 overexpression increases motility and invasion of breast cancer cells / B. Singh et al. // Int J Oncol. 2005. — Vol. 26, N. 5. — P. 1393 — 1399.
- Crew, K.D. Epidemiology of upper gastrointestinal malignancies / K.D. Crew, A.I. Neugut // Semin Oncol. 2004. — Vol. 31.-P. 450- 464.
- Crew, K.D. Epidemiology of gastric cancer / K.D. Crew, A.I. Neugut // World J. Gastroenterol. 2006. — Vol. 12. — P. 354 — 362.
- Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B / R. Mohan et al. // J Biol Chem. 2000. — Vol. 275, N. 14. — P. 10 405 — 10 412.
- Curry, T. E. JR. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle / T.E. JR. Curry, K. G. Osteen // Endocr. Rev. 2003. — Vol. 24. — P. 428 — 465.
- Cyclooxygenase-2 and p53 Expressions in Endometrial Cancer / Y.-T. Jeon et al. // Cancer Epidemiology Biomarkers &Prevention. 2004. — Vol. 13. -P. 1538−1542.
- Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast hormone receptor status in breast cancer / K. McCarthy et al. // Eur J Surg Oncol. 2006. — Vol. 32, N. 7. — P. 707 — 709.
- Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis In gastric cancer tissue / A. Tatsuguchi et al. // Hum Pathol. 2004. — Vol. 35, N. 4.-P. 488−495.
- Cyclooxygenase-2 expression correlates with diminished survival in Invasive breast cancer treated with mastectomy and radiotherapy / J.K. O’Connor et al. // Int J Radiat Oncol Biol Phys. 2004. — Vol. 58, N. 4. — P. 1034 — 1040.
- Cyclooxygenase-2 expression during carcinogenesis in the human stomach / B.P. van Rees et al. // J Pathol. 2002. — Vol. 196, N. 2. — P. 171 -179.
- Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer / A. Mitchell et al. // J Low Genit Tract Dis. 2007. — Vol. 11, N 2. -P. 80−85.
- Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters / R.M. Samaka et al. // J Egypt Natl Cane.- 2006. Vol. 18, N. 4. — P. 363 — 374.
- Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine Phosphorylase / R. Fujiwaki et al. // Hum Pathol. 2002. — Vol. 33, N. 2.-P. 213−219.
- Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome / G. Ferrandina et al. // Cancer. 2002. — Vol. 95, N. 4. — P. 801 — 807.
- Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ / E. Half et al. // Cancer Res. 2002. — Vol. 62, N. 6. -P. 1676- 1681.
- Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas- correlation with intratumoral microvessel density and apoptotic index / S. Honjo et al. // Anticancer Res. 2004. — Vol. 24, N. 3a. — P. 1439 — 1444.
- Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice / R.L. Shattuck-Brandt et al. // Gastroenterology. 2000. — Vol. 118, N. 2. — P. 337 — 345.
- Cyclooxygenase-2 in cervical neoplasia: a review / J.L. Young et al. // Gynecol Oncol.-2008.-Vol. 109, N. l.-P. 140−145.
- Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma / Sh. Zha et al. // Cancer Research.- 2001. Vol. 61. — P. 8617 — 8623.
- Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma / H. Murata et al. // Am J Gastroenterol. -1999. Vol. 94, N. 2. — P. 451 — 455.
- Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study / H. Urakawa et al. // Clin Exp Metastasis. 2009. — Vol. 26, N. 8. — P. 1005 — 1012.
- Cyclooxygenase-1 signaling is required for vascular tube formation during development / YI. Cha et al. // Dev Biol. 2005. — Vol. 282, N. 1. — P. 274−283.
- Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma / R. Ohno et al. // Cancer. 2001. — Vol. 91, N. 10. — P. 1876- 1881.
- Deryugina, E. I. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions / E.I. Deryugina, J. P. Quigley // Biochim Biophys Acta. 2010. — Vol. 1803, N. 1. — P. 103- 120.
- Developmental expression of functional cyclooxygenases in zebrafish / T. Grosser et al. // Proc Natl Acad Sci USA.- 2002 Vol. 99, N. 12. — P. 8418 — 8423.
- Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development / J.M. Shipley et al. // Mol Cell Biol. 2000. — Vol. 20, N. 13. — P. 4879 — 4887.
- De Wever, O. Role of tissue stroma in cancer cell invasion. / O. De Wever, M. Mareel // J. Pathol. 2003. — Vol. 200, N. 4. — P. 429 — 447.
- Dietary patterns and risk of gastric cancer: a case-control study in Uruguay / E. De Stefani et al. // Gastric Cancer. 2004. — Vol. 7, N. 4. — P. 211 -220.
- Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3 / T. Yokoyama et al. // Clin Exp Metast. 2004. — Vol. 21. — P. 223 — 233.
- Differential regulation of cyclooxygenase-2 expression by phytosphingosine derivatives, NAPS and TAPS, and its role in the NAPS or
- TAPS-mediated apoptosis / HJ. Kim et al. // J Invest Dermatol. 2003. — Vol. 121, N. 5. — P. 1126- 1134.
- Differential trends in the intestinal and diffuse types of gastric carcinomain the United States, 1973−2000: increase in the signet ring cell type / D.E. Henson et al. // Arch Pathol Lab Med. 2004. — Vol. 128, N. 7. — P. 765 -770.
- Dml-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development / E. Llano et al. // J. Biol. Chem. 2000. — Vol. 275. — P. 35 978 — 35 985.
- Drosophila matrix metalloproteinases are required for tissue remodeling, but not embryonic development / A. Page-McCaw et al. // Dev. Cell. 2003. -Vol. 4.-P. 95- 106.
- Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression / K.L. Andarawewa et al. // Cancer Res. 2003. -Vol. 63, N. 18. — P. 5844 — 5849.
- Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis / X. Hao et al. // J Pathol. 1999. — Vol. 187, N. 3. — P. 295 -301.
- Early onset gastric cancer: on the road to unraveling gastric carcinogenesis / A. N. Milne et al. // Curr. Mol. Med. 2007. — Vol. 7, N. 1. — P. 15−28.
- E-cadherin germline mutations in familial gastric cancer / P. Guilford et al. // Nature. 1998. — Vol. 392, N. 6674. — P. 402 — 405.
- E-cadherin immunoexpression patterns in the characterization of gastric carcinoma histotypes / P.R. Almeida et al. // J. Clin. Pathol. 2010. — Vol. 63, N. 7.-P. 635−9.
- Egeblad, M. New functions for the matrix metalloproteinases in cancer progression / M. Egeblad, Z. Werb // Nat. Rev. Cancer. 2002. — Vol. 2. — P. 161 — 174.
- Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers / G. S. Ranger et al. // J Surg Oncol. 2004. — Vol. 88, N. 2. — P. 100 — 103.
- Endoscopic mucosal resection for treatment of early gastric cancer / H. Ono et al. // Gut. 2001. — Vol. 48, N. 2. — P. 225 — 229.
- Endostatin binds to the catalytic domain of matrix metalloproteinase-2 / S. J. Lee et al. // FEBS Lett. 2002. — Vol. 519. — P. 147 — 152.
- Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase / Y. M. Kim et al. // Cancer Res. 2000. — Vol. 60. — P. 5410 — 5413.
- Endostatin inhibits human tongue carcinoma cell invasion and intra-vasation and blocks the activation of matrix metalloprotease-2, -9, and -13 / P. Nyberg et al. // J. Biol. Chem. 2003. — Vol. 278. — P. 22 404 — 22 411.
- Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis / B. G. Schneider et al. // Hum. Pathol. 2008. — Vol. 39, N. 9. -P. 1360- 1369.
- Epidemiology of gastric cancer / M. B. Piazuelo et al. // IARC Sci Publ. 2004. — Vol. 157. — P. 311 — 326.
- Eurocare-4. Survival of Cancer patients diagnosed in 1995−1999. Results and commentary / M. Sant et al. // European Journal of Cancer. 2009. — Vol. 45, N. 6.-P. 931 -991.
- Evans, J.F. Cancer and cyclooxygenase-2 (COX-2) inhibition / J.F. Evans, S.L. Kargman // Curr Pharm Des. 2004. — Vol. 10, N. 6. — P. 627 — 634.
- Ewing, J. The public and the cancer problem / J. Ewing // Science. -1938. Vol. 87, N. 2262. — P. 399 — 407.
- Expression of COX-2 in stomach carcinogenesis / N.M. Forones et al. // J Gastrointest Cancer. 2008. — Vol. 39, N. 1 — 4. — P. 4 — 10.
- Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes / M. H. Kim et al. // Gynecol Oncol. 2003. — Vol. 90, N. 1. — P. 83 — 90.
- Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract / Y. Miyata et al. // J Urol. 2005. — Vol. 173, N. l.-P. 56−60.
- Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis / Sun W. H. et al. // Jpn J Clin Oncol. 2005. — Vol. 35, N. 12. — P. 707 — 713.
- Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof / F. H. Zhang et al. // Zhonghua Yi Xue Za Zhi. 2008. — Vol. 88, N. 46. — P. 3279 — 3282.
- Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder / S. I. Mohammed et al. // Cancer Res. 1999. — Vol. 59, N. 22. — P. 5647 — 5650.
- Expression of cyclooxygenase-2 in association with clinicopatholo-gical prognostic factors and molecular markers in epithelial ovarian cancer / S. S. Seo et al. // Gynecol Oncol. 2004. — Vol. 92, N. 3. — P. 927 — 935.
- Expression of cyclooxygenase-2 in colonic polyps / M.P. Wasilewicz et al. // Pol Arch Med Wewn. 2010. — Vol. 120, N. 9. — P. 313 — 320.
- Expression of cyclooxygenase-2 in malignant and benign breast tumors / O. Watanabe et al. // Anticancer Res. 2003. — Vol. 23, N. 4. — P. 3215 — 3221.
- Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer / E. Lengyel et al. // Gynecol Oncol. 2001. — Vol. 82, N. 2. — P. 291 — 298.
- Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy / V.M. Nagy et al. // Rom J Morphol Embryol. 2011. — Vol. 52, N. 1. — P. 53 — 59.
- Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis / A. Katayama et al. // Clin Cancer Res. 2004. — Vol. 10. — P. 634 — 640.
- Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma / H. Zheng et al. // Anticancer Res. 2006. — Vol. 26, N. 5 (A). — P. 3579 — 3583.
- Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells / V.Y. Shin et al. // Toxicol Sci. 2007. — Vol. 96, N. 1.-P.21 -9.
- Gastric and intestinal claudin expression at the invasive front of gastric carcinoma / Y. Matsuda et al. // Cancer Sci. 2007. — Vol. 98, N. 7. — P. 1014 -1019.
- Gastric cancer: new genetic developments / H.T. Lynch et al. // J. Surg. Oncol. 2005. — Vol. 90. — P. 114 — 133.
- Gastric Cancer: surgical treatment and prognostic score / F. Guida et al. // Minerva Chir. 2008. — Vol. 63, N. 2. — P. 93 — 99.
- Gastric Cancer treatment guidelines. Japanese Gastric Cancer Association: 2nd edn. Tokyo.: Kanehara, 2004.
- Gastric carcinoma with osteoclast-like giant cells: a case report and review of the literature / L.-D. Zheng et al. // J of Zhejiang University Science (B). 2009. — Vol. 10, N. 3. — P. 237 — 241.
- Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II / D.W. Eom et al. // Am J Surg Pathol. -2011.-Vol. 35, N. l.-P. 84−91.
- Generation and degradation of human endostatin proteins by various proteinases / M. Ferreras et al. // FEBS Lett. 2000. — Vol. 486, N. 3. P. 247 -251.
- Gilroy, D.W. New insights into the role of COX 2 in inflammation / D.W. Gilroy, P.R. Colville-Nash // J Mol Med. 2000. — Vol. 78, N. 3. — P. 121 -129.
- Global cancer statistics / D.M. Parkin et al. // C.A. Cancer J Clin. -2005 Vol. 55, N. 2. — P. 74 — 108.
- Goldman, H. Gastrointestinal Pathology / H. Goldman, H.D. Appelman, N. Kaufman. Baltimore: Williams & Wilkins, 1990. — 386 p.
- Goseki histological grading of gastric cancer is an important predictor of outcome / I.G. Martin et al. // Gut. 1994. Vol. 35. — P. 758 — 763.
- Goseki, N. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma / N. Goseki, T. Takizawa, M. Koike // Gut 1992. — Vol. 33. — P. 606 — 612.
- Green tea polyphenol (-)-epigallocatechin 3- gallate inhibits MMP-2 secretion and MTl-MMP-driven migration in glioblastoma cells / B. Annabi et al. // Biochim. Biophys. Acta. 2002. — Vol. 1542. — P. 209 — 220.
- Gross, J. Collagenolytic activity in amphibian tissues: a tissue culture assay / J. Gross, C. M. Lapiere // Proc Natl Acad Sci USA.- 1962. Vol. 48. — P. 1014- 1022.
- Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2-inhibitor / G. Eibl et al. // Cancer Res. 2005.- Vol. 65, N. 3. — P. 982 -990.
- Grundmann, E. Histological classification of gastric cancer from initial to advanced stages / E. Grundmann, W. Schlake // Path. Res. Pract. 1982. — Vol. 173, N. 3.-P. 260−274.
- Guarino, M. Epithelial-mesenchymal transition and tumour invasion / M. Guarino // Int J Biochem Cell Biol. 2007. — Vol. 39, N. 12. — P. 2153 — 2160.
- Guo, G.L. The clinical significance of expression of cyclooxygenase-2 gene in breast cancer / G.L. Guo, Z.X. Yao, J. Wu // Zhonghua Yi Xue Za Zhi. -2003. Vol. 83, N. 19. — P. 1661 — 1664.
- Gurbuz, Y. Comparison of pathological features of gastric carcinoma in Turkey and Germany / Y. Gurbuz, G. Kloppel // J Environ Pathol Toxicol Oncol. -2005. Vol. 24, N. 4. — P. 271 — 280.
- Hamilton, S. R. Pathology and Genetics of Tumours of the Digestive System / S. R. Hamilton, L. A. Aaltonen // World health classification of tumours: International Agency for Research on Cancer (IARC). Lyon.: IARC Press, 2000. — Chapter 3.-P. 38−44.
- Hamperl, H. Die Morphologie der Tumoren / H. Hamperl // Buchner: Handbuch der allgemeinen Pathologie. Berlin-Gottingen-Heidelberg.: Springer, 1956. — Bd YI, 3.
- Haot, J. Anatomo-pathological classification of gastric tumors / J. Haot, P. Michel // Acta Gastroenterol. Belg. 1989. — Vol. 52, N. 3 — 4. — P. 340 — 352.
- Harris, R.E. Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer / R.E. Harris // Subcell Biochem. 2007. — Vol. 42. — P. 93 — 126.
- Harris, R.E. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung / R.E. Harris // Inflammophar-macology. 2009. — Vol. 17, N. 2. — P. 55 — 67.
- Helicobacter pylori and gastric cancer. The incidence of infection in personal experience / S. Caputo et al. // Minerva Chir. 2002. — Vol. 57, N. 5. -P. 649−655.
- Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics / S. Kato et al. // Cancer Sci. -2007. Vol. 98, N. 6. — P. 790 — 794.
- Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro / M. Romano et al. // Biol Chem. 1998. — Vol. 273, N. 44. — P. 28 560 — 28 563.
- Hermanek, P. The Pathologist and the Residual ® Tumor Classification / P. Hermanek, Ch. Wittekind // Path. Res. Pract. 1994. — Vol. 190. — P. 115 -123.
- Herovici, C. Picropolychrome: histological staining technic intended for the study of normal and pathological connective tissue / C. Herovici // Rev Fr Etud Clin Biol 1963. — Vol. 8. — P. 88 — 89.
- HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi sarcoma / C. Sgadari et al. // Nat. Med. 2002. — Vol. 8, N. 3.-P. 225−232.
- Hojilla, C. V. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development / C. V. Hojilla, F. F. Mohammed, R. Khokha // Br. J. Cancer.-2003.-Vol. 89.-P. 1817- 1821.
- Housekeeping genes as internal standards in cancer research / N. Janssens et al. // Mol Diagn. 2004. — Vol. 8, N. 2. — P. 107 — 113.
- Hulboy, D.L. Matrix metalloproteinases as mediators of reproductive function / D.L. Hulboy, L. A. Rudolph, L. M. Matrisian // Mol. Hum. Reprod. -1997.-Vol. 3.-P. 27−45.
- Hutchison, R. COX-2-selective NSAIDs / R. Hutchison // Am J Nurs. -2004. Vol. 104, N. 3. — P. 52−55.
- Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas / N. J. Agnantis et al. // Hepatogastroenterology. -1991. Vol. 38, N. 3. — P. 239 — 242.
- Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival /
- D. Lazar et al. // Rom J Morphol Embryol. 2008. — Vol. 49, N. 3. — P. 371 -379.
- Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma / M. Raica et al. // Rom. J. Morphol. Embryol. 2008. — Vol. 49, N. 1. — P. 37 — 42.
- Incidence of esophageal and gastric cancers among Hispanics, non-Hispanics whites and non-Hispanics blacks in the United States: subsite and histology differences / X. Wu et al. // Cancer Causes Control. 2007. — Vol. 18. -P. 585−593.
- Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs / M. A. Molina et al. // Cancer Res. 1999. — Vol. 59, N. 17. — P. 4356 — 4362.
- Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer / L. Franco et al. // Prostaglandins Others Lipid Mediat. 2004. — Vol. 73, N. 1 — 2. — P. 51 — 58.
- Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori / EM. El-Omar et al. // Gastroenterology. 2000. — Vol. 118, N. 1. — P. 22 — 30.
- Induction of Cyclooxygenase-2 Expression by Hepatitis B Virus Depends on Demethylation-associated Recruitment of Transcription Factors to the Promoter / X. Yue et al. // Virol J. 2011. — Vol. 8. — P. 118.
- Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia / A. Ruol et al. // Cancer. 2000. — Vol. 88. — P. 2520 — 2528.
- Ip, Y. C. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma / Y.C. Ip, S.T. Cheung, S.T. Fan // Mol Carcinog. 2007. -Vol. 46, N. 3. — P. 225−230.
- Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? / A. Caporale et al. // Clin. Gastroenterol. Hepatol. 2005. — Vol. 3, N. 4.-P. 370−375.
- Is screening for and surveillance of atrophic gastritis advisable / G. Nadrone et al. // Dig. Dis. 2007. — Vol. 25. — P. 214 — 217.
- Jakszyn, P. Nitrosamine and related food intake and gastric and oesophageal risk: a systematic review of the epidemiological evidence / P. Jakszyn, C. A. Gonzalez // World J. Gastroenterol. 2006. — Vol. 12. — P. 4296 — 4303.
- Jarvi, O. On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer / O. Jarvi, P. Lauren // Acta pathol. microbiol. scand. 1951. — Vol. 29. — P. 26 — 44.
- Jiang, Y. Complex roles of tissue inhibitors of metalloproteinases in cancer / Y. Jiang, I.D. Goldberg, Y.E. Shi // Oncogene. 2002. — Vol. 21. — P. 2245 — 2252.
- Kaminishi, M. The Diversity of Gastric Carcinoma. Pathogenesis, Diagnosis, and Treatment / M. Kaminishi, K. Takubo, K. Mafune. Tokyo.: Springer — Verlag, 2005. — 353 p.
- Kang, C.H. Correlation of COX-2 expression in stromal cells with high stage, high grade, and poor prognosis in urothelial carcinoma of upper urinarytracts / C.H. Kang, P.H. Chiang, S.C. Huang // Urology. 2008. — Vol. 72, N. 1. — P. 153- 157.
- Kato, Y. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells / Y. Kato, T. Yamashita, M. Ishilcawa // Oncol Rep. 2002. — Vol. 9, N. 3. — P. 565 -569.
- Kawai, N. Cyclooxygenases and colon cancer / N. Kawai, M. Tsujii, S. Tsuji // Prostaglandins Other Lipid Mediat. 2002. — Vol. 68 — 69. — P. 187 — 196.
- Kerkela, E. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer / E. Kerkela, U. Saarialho-Kere // Exp Dermatol.-2003.-Vol. 12.-P. 109−125.
- Kohrmann, A. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature / A. Kohrmann // BMC Cancer. 2009. — Vol. 9. — P. 188.
- Kubo, A. Marked multi-ethnic variation of variation of esophageal and gastric cardia carcinomas within the United States / A. Kubo, D. A. Corley // Am J Gastroenterol. 2004. — Vol. 99, N. 4. — P. 582 — 588.
- Kubo, T. Histologic appearance of gastric carcinoma in high and low mortality countries: comparison between Kyushu, Japan and Minnesota, USA / T. Kubo // Cancer. 1971. — Vol. 28, N. 3. — P. 726 — 734.
- Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up / L.M. Kelly et al. // Eur J Surg Oncol. 2003. — Vol. 29, N. 9.-P. 707−710.
- Larsson, S.C. Processed meat consumption, dietary nitrosamines and stomach cancer risk in a cohort of Swedish women / S.C. Larsson, L. Berkvist, A. Wolk // Int. J. Cancer. 2006. — Vol. 119. — P. 915 — 919.
- Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a Histo-Clinical Classification / P. Lauren // Acta path, et microbial, scandinav. 1965. — Vol. 64. -P. 31−49.
- Li, L. Mast cell and immune inhibitory receptors / L. Li, Z. Yao // Cell Mol Immunol. 2004. — Vol. 1, N. 6. — P. 408 — 415.
- Lim, S.C. Fas-related apoptosis in gastric adenocarcinoma / S. C. Lim // Oncol Rep. 2003. — Vol. 10, N. 1. — P. 57 — 63.
- Lindblad, M. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer / M. Lindblad, J. Lagergren, L.A. Garcia Rodriguez // Cancer Epidemiol. Biomarkers Prev. 2005. — Vol. 14. — P. 444 — 450.
- Lochhead, P. Gastric cancer / P. Lochhead, E.M. El-Omar // Br. Med Bull. 2008. — Vol. 85. — P. 87 — 100.
- Loss of collagenase-2 confers increased skin tumor susceptibility to male mice / M. Balbin et al. // Nat Genet. 2003. — Vol. 35, N. 3. — P. 252 — 257.
- Malfertheiner, P. Can gastric cancer be prevented by Helicobacter pylori eradication? / P. Malfertheiner, L. C. Fry, K. Monkemuller // Best Pract Res Clin Gastroenterol. 2006. — Vol. 20, N. 4. — P. 709 — 719.
- Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial / S.R. Bramhall et al. // Br J Cancer. — 2002. — Vol. 86.-P. 1864−1870.
- Marnett, L. J. The COXIB experience: a look in the rearview mirror / L.J. Marnett // Annu Rev Pharmacol Toxicol. 2009. — Vol. 49. — P. 265 — 290.
- Martin, M.D. The other side of MMPs: protective roles in tumor progression / M.D. Martin, L.M. Matrisian // Cancer Metastasis Rev. 2007. -Vol. 26, N. 3 — 4. — P. 717 — 724.
- Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations / Caruso R.A. et al. // Anticancer Res. 2007. — Vol. 27, N. 1 A.-P. 391−394.
- Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury / Q. Li et al. // Cell. -2002.- 111.-P. 635−46.
- Matrix metalloproteinase inhibitors and cancer: trials and tribulations / L. M. Coussens et al. // Science. 2002. — Vol. 295. — P. 2387 — 2392.
- Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy / E. Rahko et al. // Anticancer Res. 2004. -Vol. 24, N. 6.4247−4253.
- Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer / F.J.G.M. Kubben et al. // British Journal of Cancer. 2006. — Vol. 94. -P. 1035−1040.
- Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo / G.A. McQuibban et al. // Blood. 2002. — Vol. 100. — P. 1160- 1167.
- Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies / A.R. Folgueras et al. // Int J Dev Biol 2004. — Vol. 48, N. 5 — 6. — P. 411 — 424.
- McCawley, L.J. Matrix metalloproteinases: they’re not just for matrix anymore! / L.J. McCawley, L.M. Matrisian // Curr Opin Cell Biol. 2001 — Vol. 13.-P. 534−540.
- Medina-Franco, H. Preemptive total gastrectomy for hereditary gastric cancer / H. Medina-Franco, R. Barreto-Zuniga, M.N. Garcia-Alvarez // J. Gastrointest. Surg. 2007. — Vol. 11. — P. 314 — 317.
- Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis / N.E. Sounni et al. // Matrix Biol. 2003. — Vol. 22. — P. 55 — 61.
- Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling / B.G. Galvez et al. // J. Biol. Chem. 2001. — Vol. 276. — P. 37 491 -37 500.
- Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix / K.B. Hotary // Cell. -2003.-Vol. 114.-P. 33−45.
- Metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients / S.O. Wiirtz et al. // Mol Cell Proteomics. 2005. — Vol. 4 (a). -P. 483−491.
- Mills, P.K. Agricultural exposures and gastric cancer risk in Hispanic farm workers in California / P.K. Mills, R.C. Yang // Environ. Res. 2007. — Vol. 104.-P. 282−289.
- Ming, Si-Chun. Gastric carcinoma. A pathobiological classification / SiCh. Ming // Cancer. 1977. — Vol. 39. — P. 2475 — 2485.
- MMP-2 and MMP-9 synergize in promoting choroidal neovascularization / V. Lambert et al. // FASEB J. 2003. — Vol. 17, N. 15. — P. 2290 — 2292.
- MMP-9 supplied by bone marrow-derived cells contributes to skin carcino-genesis / L. M. Coussens et al. // Cell. 2000. — Vol. 103. — P. 481 -490.
- Molecular biology of gastric cancer / Cervantes A. et al. // Clin. Transl. Oncol. 2007. — Vol. 9, 4. — P. 208 — 215.
- Morson, B.C. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa / B.C. Morson // Brit. J. Cancer. 1955. — Vol. 9. — P. 377 -385.
- Mousavi, S.M. Gastric cancer in Iran 1966 2006 / S.M. Mousavi, M.H. Somi // Asian Pac. J. Cancer Prev. — 2009. — Vol. 10, N. 3. — P. 407 — 412.
- Miiller, G. General guidelines for surgery and pathology of the Japanese Research Society for Gastric Cancer / G. Muller // Chirurg. 1985 — Vol. — 56, N. 8.-P. 539−552.
- Mulligan, R.M. Histogenesis and biologic behavior of gastric carcinoma: study of one hundred thirty-eight cases / R.M. Mulligan, R.R. Rember // A.M.A. Arch Pathol. 1954. — Vol. 58, N. 1. — P. 1 — 25.
- Mulligan, R.M. Histogenesis and biologic behavior of gastric carcinoma / R.M. Mulligan // Pathol Annu. 1972. — Vol. 7. — P. 349 — 415.
- Murakami, T. Early cancer of the stomach / T. Murakami // World J Surg. 1979. — Vol. 3, N. 6. — P. 685 — 692.
- Mutation of mitochondrial 12S rRNA in gastric carcinomas and its significance / C.B. Han et al. // Zhonghua Zhong Liu Za Zhi. 2005. -Vol. 27, N. 5.-P. 260−264.
- Nagase, H. Structure and function of matrix metalloproteinases and TIMPs / H. Nagase, R. Visse, G. Murphy // Cardiovasc Res. 2006. — Vol. 69, N. 3.-P. 562−573.
- Nakamura, K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances / K. Nakamura, H. Sugano, K. Takagi // Gann. 1968. — Vol. 59, N. 3. — P. 251 — 258.
- Nassar, H. Carcinomas with micropapillary morphology: clinical significance and current concepts / H. Nassar // Adv. Anat. Pathol. 2004. — Vol. 11, N. 6.-P. 297−303.
- Ny, T.G. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems / T.G. Ny, P. Wahlberg, I. Brandstrom // J. Mol. Cell. Endocrinol. 2002. — Vol. 187. — P. 29 -38.
- Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers / C. Jansson et al. // Cancer Causes Control. 2005. — Vol. 16. — P. 755 — 764.
- Opposing risk of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity / F. Kamangar et al. // J. Natl. Cancer Inst. 2006. — Vol. 98. — P. 1445 — 1452.
- Ouban, A. Claudins in human cancer: a review / A. Ouban, A.A. Ahmed // Histol. Histopathol. 2010. — Vol. 25, N. 1. — P. 83 — 90.
- Overall, C.M. Strategies for MMP inhibition in cancer: innovations for the post-trial era / C.M. Overall, C. Lopez-Otin // Nat. Rev. Cancer. 2002. — Vol. 2.-P. 657−672.
- Overexpression of cyclooxygenase-2 is associated with a favorable Prognostic phenotype in breast carcinoma / L. Nakopoulou et al. // Pathobiology. 2005. — Vol. 72, N. 5. — P. 241 — 249.
- Page-McCaw, A. Matrix metalloproteinases and the regulation of tissue remodelling / A. Page-McCaw, A. J. Ewald, Z. Werb // Nat Rev Mol Cell Biol. -2007.-Vol. 8.-P. 211 -233.
- Peskar, B.M. Role of cyclooxygenase isoforms in gastric mucosal / defence B. M. Peskar // J Physiol Paris. 2001. — Vol. 95, N. 1 — 6. — P. 3 — 9.
- Peter, S. Helicobacter pylori and gastric cancer: the causal relationship / S. Peter, C. Beglinger // Digestion. 2007. — Vol. 75, N. 1. — P. 25 — 35.
- Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme / M.D. Groves et al. // J Clin Oncol. 2002. — Vol. 20, N. 5. — P. 1383 — 1388.
- Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis / M.M. Tian et al. // World J Gastroenterol. 2007. — Vol. 13, N. 23. — P. 3189 — 3198.
- Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer / K. Przybylowska et al. // Breast Cancer Res Treat. 2006. — Vol. 95. — P. 65 — 72.
- P 53 polymorphism and gastric cancer: a meta-analysis of the literature / Y. Zhou et al. // Int. J. Cancer. 2007. — Vol. 121. — P. 1481 — 1486.
- Pozzi, A. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis / A. Pozzi, W.F. Levine, H.A. Gardner // Oncogene.- 2002. Vol. 21. — P. 272 — 281.
- Prabhu, S.R. Role of Helicobacter pylori in gastric carcinoma / S.R. Prabhu, A.D. Amrapurkar, D.N. Amrapurkar // Natl. Med. J. India. 1995. — Vol. 8.-P. 58−60.
- Presence of poorly differentiated component correlated with submucosal invasion in the early diffuse-type gastric cancer / T. Kuroda et al. // Hepatogastroenterology. 2008. — Vol. 55, N. 88. — P. 2264 — 2268.
- Presence of vascular adventitial fibroblastic cells in diffuse-type gastric carcinomas / H. Nakayamaet al. // J Clin Pathol. 2004. — Vol. 57, N. 9. — P. 970 — 972.
- Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy / G. Palestro et al. // World J Gastroenterol. 2005. — Vol. 11, N. 45. — P. 7131 -7135.
- Prinz, C. H pylori and gastric cancer: shifting the global burden / C. Prinz, S. Schwendy, P. Voland // World J Gastroenterol. 2006. — Vol. 12, N. 34. — P. 5458 — 5464.
- Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer / A. Ristimaki et al. // Cancer Res. 2002. — Vol. 62, N. 3. — P. 632 -635.
- Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family / D. Hackenson et al. // JSLS. 2010. -Vol. 14, N. 3. — P. 348−352.
- Proteolysis in human breast cancer / E. A. Garbett et al. // Mol Pathol.- 2000. Vol. 53, N. 2. — P. 99 — 106.
- Rainsford, K.D. Anti-inflammatory drugs in the 21st century / K.D. Rainsford // Subcell Biochem. 2007. — Vol. 42. — P. 3 — 27.
- Raj, A. Occupation and gastric cancer / A. Raj, J.F. Mayberry, T. Podas 11 Postgrad. Med. J. 2003. — Vol. 79. — P. 252 — 258.
- Recent patterns in gastric cancer: a global overview / P. Bertuccio et al. // Int. J Cancer. 2009. — Vol. 125, N. 3. — P. 666 — 673.
- Reduced angiogenesis and tumor progression in gelatinase A-deficient mice/T. Itoh et al.//Cancer Res. 1998. — Vol. 58.-P. 1048−1051.
- Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation / A.C. Hagglund et al. // Endocrinology 1999. — Vol. 140. — P. 4351 -4358.
- Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells / M. Iwasaki et al. // Oncol Rep. 2002. — Vol. 9. — P. 565 — 569.
- Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren’s histologic subtypes of gastric carcinomas / V. Baressi et al. // Eur. J. Histochem. 2006. — Vol. 50, N. 4. — P. 301 — 309.
- Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas / L. Li et al. // Ai Zheng. 2002. — Vol. 21, N. 3. — P. 305 — 310.
- Relationships between mucinous gastric carcinoma, MUC2 expression and survival / E. Leteurtre et al. // World J. Gastroenterol. 2006. — Vol. 12, N. 921.-P. 3324−3331.
- Risk factors for lymph node metastasis from gastric cancers with submucosal invasion / Y. Tajima et al. // Ann Surg Oncol. 2010. — Vol. 17, N. 6.-P. 1597- 1604.
- Rivera, F. Chemotherapy of advanced gastric cancer / F. Rivera, M.E. Vega Villegas, M.F. Lopez -Brea // Cancer Treat Rev. — 2007. — Vol. 33. — P. 315−324.
- Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma / Y. Ohno et al. // Int J Cancer. 2005. — Vol. 114, N. 5. -P. 696−701.
- Roles of Matrix Metalloproteinases in tumor metastasis and angiogenesis / S.O. Yoon et al. // Journal of Biochemistry and Molecular Biology. 2003. -Vol. 36, No. l.-P. 128- 137.
- Rouzer, C.A. Cyclooxygenases: structural and functional insights / C.A. Rouzer, L.J. Marnett // J Lipid Res. 2009. — Suppl: S. P. 29 — 34.
- Safety of extended endoscopic mucosal resection and endoscopic submucosal dissection following the Japanese Gastric Cancer Association treatment guidelines / Y.S. Jee et al. // Br. J. Surg. 2009. — Vol. 96, N. 10. — P. 1157 -1161.
- Seiki, M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion / M. Seiki // Cancer Lett. 2003. — Vol. 194. — P. 1 — 11.
- Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest / K. Yazawa et al. // Int J Cancer. -2005. Vol. 113, N. 4. — P. 541 — 548.
- Selser, J.M. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis / J.M. Selser // AACN Adv. Crit. Care. 2007. — Vol. 18. -P. 119−126.
- Severely impaired wound healing in the collagenase-resistant mouse / A.H. Beare et al. // J Invest Dermatol. 2003. — Vol. 120, N. 1. — P. 153 — 163.
- Shikata, K. Effect of dietary factors on gastric cancer / K. Shikata, Y. Kiyohara, M. Iida // Nippon Shokakibyo Gakkai Zasshi. 2006. — Vol. 103, N. 5. -P. 501 -507.
- Sinicrope, F.A. Role of cyclooxygenase-2 in colorectal cancer / F.A. Sinicrope, S. Gill // Cancer Metastasis Rev. 2004. — Vol. 23, N. 1. — P. 63 — 75.
- Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis / B.S. Wiseman et al. // J. Cell Biol.-2003.-Vol. 162.-P. 1123−1133.
- Siveen, K.S. Role of macrophages in tumour progression / K.S. Siveen, G. Kuttan // Immunol. Lett. 2009. — Vol. 123, N. 2. — P. 97 — 102.
- Smith, B.R. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young / B.R. Smith, B.E. Stabile // Arch. Surg. 2009. -Vol. 144, N. 6.-P. 506−510.
- Smith, W.L. Cyclooxygenases: structural, cellular, and molecular biology / W.L. Smith, D.L. DeWitt, R.M. Garavito // Annu Rev Biochem. 2000. -Vol. 69.-P. 145−82.
- Snoek-van Beurden, P.A. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors / P.A. Snoek-van Beurden, J.W. Von den Hoff// Biotechniques. 2005. — Vol. 38. — P. 73 — 83.
- Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC -EURGAST) / G. Nagel et al. // Int J of Epidemiol. 2007. — Vol. 36, N. 1. — P. 66−76.
- Stamenkovic, I. Matrix metalloproteinases in tumor invasion and metastasis / I. Stamenkovic // Semin Cancer Biol. 2000. — Vol. 10. — P. 415 -433.
- Sternlicht, M.D. How matrix metalloproteinases regulate cell behaviour / M.D. Sternlicht, Z. Werb // Annu Rev Cell Dev Biol. 2001. — Vol. 17. — P. 463 -516.
- Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery / Y. Jiang et al. // Cancer Res. 2001. -Vol. 61.-P. 2365−2370.
- Stout, A.P. Tumors of the stomach / A.P. Stout // Atlas of tumor pathology. Washington, D.C.: Armed Forces Inst. Path., 1959. — Vol. XX.
- Strategies for gastric cancer in the modern era / S. Takayama et al. // World J. Gastrointest. Oncol. 2010. — Vol. 2, N. 9. — P. 335 — 341.
- Structure and function of matrix metalloproteinases and TIMPs / H.C. Li et al. // Cardiovasc Res. 2006. — Vol. 69, N. 3. — P. 562 — 573.
- Study of matrix metalloproteinases and their inhibitors in breast cancer / F.J. Vizoso et al. // B J Cancer. 2007. — Vol. 96. — P. 903 — 911.
- Subbaramaiah, K. Cyclooxygenase 2: a molecular target for cancer prevention and treatment / K. Subbaramaiah, A.J. Dannenberg // Trends Pharmacol Sci. 2003. — Vol. 24, N. 2. — P. 96 — 102.
- Sugano, H. Pathologic studies of human gastric cancer / H. Sugano, K. Nakamura, Y. Kato // Acta Pathol. Jpn. 1982. — Vol. 32, Suppl. 2. — P. 329 — 347.
- Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes / M. Nakada et al. // Cancer Res. 2001. — Vol. 61. -P. 8896−8902.
- Survival effects of cyclooxygenase-2 and 12-lipooxygenase in Egyptian women with operable breast cancer / A.A. Zeeneldinet al. // Indian J Cancer. -2009. Vol. 46, N. 1. — P. 54 — 60.
- Takanami, I. M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma / I. Takanami, K. Takeuchi, M. Naruke // Cancer. 2000. — Vol. 88. — P. 2686 — 2692.
- Taking cell-matrix adhesions to the third dimension / E. Cukierman et al. // Science. 2001. — Vol. 294. — P. 1708 — 1712.
- Tan, Y.K. Early diagnosis of early gastric cancer I Y.K. Tan, J.W. Fielding 11 Eur. J. Gastroenterol. Hepatol. 2006. — Vol. 18. — P. 821 — 829.
- The classification of gastric carcinoma / R. Schindler et al. // Surg. Gynec. Obstet. 1941. — Vol. 73. — P. 30 — 39.
- The histogenesis and biologic behavior of primary human malignant melanomas of the skin / W.H. Jr. Clark et al. // Cancer. Res. 1969. — Vol. 29, N. 3.-P. 705−727.
- Therapeutic microRNA strategies in human cancer / C. Li et al. // AAPS J. 2009. — Vol. 11, N. 4. — P. 747 — 757.
- The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma / F.J. Zhao et al. // Zhonghua Nei Ke Za Zhi. 2009. — Vol. 48, N. 2. — P. 114 — 117.
- The role of E-cadherin expression in non-small cell lung cancer / S.C. Urn et al. // J Korean Med Sci. 2000. — Vol. 15, N. 5. — P. 501 — 506.
- The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study / J.J. Yang et al. // BMC Cancer.-2009.-Vol. 17.-P. 9−238.
- The Symposium on the Geographical Pathology of Gastro-Intestinal Cancer. Acta Un. Int. Cancer, 1961. Vol. 17. — P. 283 — 286.
- TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism/D.W. Seo et al.//Cell.-2003.-Vol. 114.-P. 171−180.
- Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with non-small cell lung carcinoma who undergo resection with curative intent / V. Gouyer et al. // Cancer. 2005. — Vol. 103. — P. 1676 -1684.
- Tissue inhibitor of metalloproteinases-1 in breast cancer / S.O. Wiirtz et al. // Endocr Relat Cancer. 2005. — Vol. 12 (b). — P. 215 — 227.
- Trends in clinicopathologic characteristics and prognostic predictors of survival outcome in black patients with gastric carcinoma: a single institution’s experience / C.U. Ihemelandu et al. // J Surg Res. 2009. — Vol. 156, N. 2. — P. 325−332.
- Tumors of the Mammary Gland: Atlas of Tumor Pathology / edited by P.P. Rosen, H.A. Oberman. Maryland.: Armed Forces Institute of Pathology, Washington, D.C., 1993. — Fascicle 7.-390 p.
- Tumour invasion and matrix metalloproteinases / M. Polette et al. 11 Crit Rev Oncol Hematol. 2004. — Vol. 49. — P. 179 — 186.
- Two distinct aethiologies of cardia cancer- evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status / S. Hansen et al. // Gut. 2007. — Vol. 56. — P. 918 — 925.
- Uefuji, K. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer / K. Uefuji, T. Ichikura, H. Mochizuki // Clin Cancer Res. 2000. — Vol. 6, N. 1. — P. 135 — 138.
- Uefuji, K. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas / K. Uefuji, T. Ichikura, H. Mochizuki // J Surg Oncol. -2001. Vol. 76, N. 1. -P. 26 — 30.
- Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness / H.S. Han et al. // J. Gastroenterol. Hepatol. 2009. — Vol. 24, N. 4.-P. 658−666.
- Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease / L.S. Hammes et al. // Gynecol Oncol. 2008. — Vol. 110, N. 3. — P. 445 — 451.
- Urinary release of 72 and 92 kDa gelatinases, TIMPs, N-GAL and conventional prognostic factors in urothelial carcinomas / F. Monier et al. // Eur Urol. 2002. — Vol. 42. — P. 356 — 363.
- Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma / Y. S. Seo et al. // Dig. Dis. Sci. 2007. — Vol. 52, N. 3. — P. 753 — 759.
- Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma / Y. Maehara et al. // Surgery. 2000. — Vol. 128, N. 3. — P. 408−416.
- Verstappen, J. Tissue Inhibitors of Metalloproteinases (TIMPs): Their Biological Functions and Involvement in Oral Disease / J. Verstappen and J.W. Von den Hoff// Journal of Dental Research. 2006. — Vol. 85, No. 12. — P. 1074 -1084.
- Vihinen, P. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets / P. Vihinen, V.M. Kahari // Int. J. Cancer. 2002. — Vol. 99. -P. 157−166.
- Vu, T. H. Matrix metalloproteinases: effectors of development and normal physiology / T.H. Vu, Z. Werb // Genes Dev. 2000. — Vol. 14. — P. 2123 -2133.
- Wattenberg, L.W. Histochemical study of aminopeptidase in metaplasia and carcinoma of the stomach / L.W. Wattenberg // A.M.A. Arch. Path. 1959. -Vol. 67.-P. 281−286.
- WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production / S. Hamano et al. // Immunity. 2003. — Vol. 19, N. 5. — P. 657 — 667.
- Yang, Z. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2 / Z. Yang, D.K. Strickland, P. Bornstein // J. Biol. Chem. 2001. — Vol. 276, N. 11. -P. 8403 — 8408.
- Yu, Q. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis / Q. Yu, I. Stamenkovic // Genes Dev. 2000. — Vol. 14. — P. 163 — 176.
- Zucker, S. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment / S. Zucker, J. Cao, W.T. Chen // Oncogene. 2000. -Vol. 9.-P. 6642−6650.